Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
Departamento
Centro Nacional de Biotecnología
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro Nacional de Biotecnología (7)
2024
-
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines, Vol. 12, Núm. 1
-
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)
npj Vaccines
-
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes and Infections, Vol. 13, Núm. 1
-
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines, Vol. 9, Núm. 1
2023
-
Viral protein nanoparticles (Part 1): Pharmaceutical characteristics
European Journal of Pharmaceutical Sciences, Vol. 187
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2000
-
Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells
Virology, Vol. 278, Núm. 2, pp. 322-331